Christine Victoria Ichim

Title: Christine Victoria Ichim: Innovator in Nuclear Receptor Modulation

Introduction

Christine Victoria Ichim is a prominent inventor based in Spring Valley, CA (US). She has made significant contributions to the field of biopharmaceuticals, particularly in the modulation of nuclear receptors. With a total of 2 patents, her work focuses on innovative methods that can lead to advancements in therapeutic applications.

Latest Patents

Ichim's latest patents include "Methods of screening compounds that can modulate NR2F6 by displacement of a reference ligand." This invention discloses compositions of matter, protocols, and methods for screening test compounds to identify agonists and antagonists of the orphan nuclear receptor NR2F6. The process involves measuring the ability of a test compound to occupy the active site of NR2F6 in the presence of a reference compound. Another significant patent is "Modulation of NR2F6 and methods and uses thereof," which provides methods for modulating NR2F6 in a cell or animal in need thereof by administering an effective amount of a NR2F6 modulator.

Career Highlights

Christine Ichim is currently associated with Regen Biopharma, Inc., where she continues to push the boundaries of research in her field. Her innovative approaches have the potential to lead to new treatments for various diseases, showcasing her dedication to advancing medical science.

Collaborations

Ichim collaborates with Richard Alexander Wells, further enhancing her research capabilities and expanding the impact of her work in the biopharmaceutical industry.

Conclusion

Christine Victoria Ichim is a trailblazer in the field of nuclear receptor modulation, with her patents paving the way for future innovations in therapeutic applications. Her contributions to science and medicine are invaluable, and her work continues to inspire advancements in the industry.